Critical Alert
ANTHONY TRINH Recalls SILINTAN 25/pills
This is a Class I recall — the most serious type. There is a reasonable probability of serious health consequences or death.
Source: FDA
CriticalRecall #D-0388-2026Drug / Pharmaceutical
ANTHONY TRINH Recalls SILINTAN 25/pills
ANTHONY TRINH, 123Herbals LLC · Class I — Most Serious
Product Description
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Reason for Recall
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
FDA Classification
Class I — Most Serious
A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Distribution
USA nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class I recall — the FDA's most urgent classification — has been issued for a pharmaceutical product recalled by ANTHONY TRINH, 123Herbals LLC on October 20, 2025. Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. This product was distributed in USA nationwide. Class I recalls indicate a reasonable probability of serious health consequences or death. Consumers should stop using this product immediately.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.